EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 529.27B
Enterprise Value 329.68B
Trailing P/E 45.90
Forward P/E 126.67
PEG Ratio (5 yr expected) 12.10
Price/Sales (ttm)8.25
Price/Book (mrq)9.24
Enterprise Value/Revenue 38.36
Enterprise Value/EBITDA 627.66

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin 18.50%
Operating Margin (ttm)27.98%

Management Effectiveness

Return on Assets (ttm)11.47%
Return on Equity (ttm)21.51%

Income Statement

Revenue (ttm)3.55B
Revenue Per Share (ttm)16.86
Quarterly Revenue Growth (yoy)12.10%
Gross Profit (ttm)2.56B
Net Income Avi to Common (ttm)656.6M
Diluted EPS (ttm)3.05
Quarterly Earnings Growth (yoy)51.90%

Balance Sheet

Total Cash (mrq)1.4B
Total Cash Per Share (mrq)6.69
Total Debt (mrq)1.19B
Total Debt/Equity (mrq)37.71
Current Ratio (mrq)2.28
Book Value Per Share (mrq)15.12

Cash Flow Statement

Operating Cash Flow (ttm)966.2M
Levered Free Cash Flow (ttm)440.98M

Trading Information

Stock Price History

Beta 0.72
52-Week Change 322.04%
S&P500 52-Week Change 316.98%
52 Week High 3156.87
52 Week Low 3100.20
50-Day Moving Average 3145.24
200-Day Moving Average 3139.74

Share Statistics

Avg Vol (3 month) 31.25M
Avg Vol (10 day) 31.16M
Shares Outstanding 5209.39M
Float 207.79M
% Held by Insiders 13.94%
% Held by Institutions 10.00%
Shares Short (Jul 13, 2018) 42.61M
Short Ratio (Jul 13, 2018) 42.1
Short % of Float (Jul 13, 2018) 41.39%
Short % of Shares Outstanding (Jul 13, 2018) 41.25%
Shares Short (prior month Jun 15, 2018) 43.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Dec 14, 2015